earnings
ZN
NASDAQ · ZNTL
Zentalis Pharmaceuticals, Inc.
Healthcare · Biotechnology
$2.61
Down-$0.09 (-3.26%)
Updated Oct 2, 2026, 10:04 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 104.4M
- P/E ratio
- -0.64
- Dividend yield
- 0.00%
- 52-week range
- $1.21 – $6.95
- Volume
- 1.9M
- Avg. volume
- 673.52K
Price performance · ZNTL
ZNTL price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 1, 2026
ZNTL closed at $2.61 after 20 trading sessions, down 36.62% for the selected period.
- Last close
- $2.61
- Period change
- -36.62%
- Period low
- $2.60
- Period high
- $4.11
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 1, 2026 | $2.74 | $2.78 | $2.58 | $2.605 | 1.9M |
| Sep 30, 2026 | $2.71 | $2.795 | $2.605 | $2.77 | 1.01M |
| Sep 29, 2026 | $2.62 | $2.81 | $2.57 | $2.715 | 4.78M |
| Sep 28, 2026 | $2.70 | $2.70 | $2.57 | $2.60 | 1.27M |
| Sep 25, 2026 | $2.75 | $2.77 | $2.65 | $2.70 | 1.07M |
| Sep 24, 2026 | $2.84 | $2.89 | $2.73 | $2.75 | 1.17M |
| Sep 23, 2026 | $3.07 | $3.09 | $2.78 | $2.87 | 1.45M |
| Sep 22, 2026 | $3.07 | $3.14 | $3.01 | $3.08 | 956.31K |
| Sep 21, 2026 | $3.15 | $3.15 | $2.995 | $3.03 | 675.64K |
| Sep 18, 2026 | $3.07 | $3.18 | $2.99 | $3.11 | 1.26M |
| Sep 17, 2026 | $3.18 | $3.215 | $3.02 | $3.08 | 1.09M |
| Sep 16, 2026 | $3.23 | $3.26 | $3.035 | $3.10 | 1.23M |
| Sep 15, 2026 | $3.51 | $3.51 | $3.12 | $3.13 | 1.4M |
| Sep 14, 2026 | $3.47 | $3.57 | $3.44 | $3.50 | 750.36K |
| Sep 11, 2026 | $3.63 | $3.67 | $3.465 | $3.51 | 787.86K |
| Sep 10, 2026 | $3.74 | $3.765 | $3.555 | $3.59 | 864.21K |
| Sep 9, 2026 | $3.99 | $4.039 | $3.79 | $3.80 | 782.55K |
| Sep 8, 2026 | $4.00 | $4.10 | $3.885 | $4.03 | 519.17K |
| Sep 4, 2026 | $4.05 | $4.1851 | $3.92 | $3.99 | 1M |
| Sep 3, 2026 | $3.80 | $4.12 | $3.73 | $4.11 | 1.37M |
Latest ZNTL news
The latest Smart Investors Daily articles mentioning ZNTL.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…